Vitiligo clinical trials play an important role in improving understanding of the condition and developing future treatment options. As research activity increases, many people affected by vitiligo ask how trials work, where to find reliable information, and whether taking part may be suitable for them.

This page explains how vitiligo clinical trials work, where to find trusted research information, and how The Vitiligo Society supports safe engagement with research, without promoting or endorsing individual studies.

Vitiligo clinical trials are carefully designed research studies that investigate new or existing treatments, approaches to care, or quality‑of‑life support. Researchers use trials to answer specific questions about safety, effectiveness, and longer‑term outcomes. For example, vitiligo trials may explore:

Before a trial can take place in the UK, it must receive approval from the Medicines and Healthcare products Regulatory Agency (MHRA) and relevant ethics committees. This ensures that research is conducted safely, ethically and with informed consent.

Although clinical trials contribute to progress, they are not suitable for everyone. Participation is always voluntary, and people should take time to understand what involvement means. Importantly:

Therefore, trial participation should never replace routine medical care. People should discuss any research opportunity with a registered dermatologist or healthcare professional who understands their individual situation.

Because research activity changes frequently, the Vitiligo Society does not maintain a live list of clinical trials. Research activity changes frequently, and study availability varies by location and eligibility. Instead, we encourage people to use trusted, official sources to explore current research opportunities:

These platforms allow people to search for trials and explain how studies operate. However, finding a study does not mean it will be appropriate. For that reason, discussion with a healthcare professional remains essential.

In practice, people already under dermatology or specialist care are often best placed to hear about relevant research directly through their clinical teams. Dermatologists and vitiligo specialists may:

If you are interested in research, raising this with your healthcare professional is an important first step.

The Vitiligo Society supports vitiligo research in ways that are ethical, transparent and patient‑centred. Rather than promoting all the active trials, we focus on helping people engage safely and realistically with research. Specifically, we may:

When we are approached to support recruitment for a study, information is usually shared through direct communications with our members, such as emailed with monthly newsletter, or posted on our online magazine, The VitLife.

We do not endorse individual studies or treatments, and we encourage people to discuss any research opportunities with their healthcare professional.

Research is essential for progress, but it takes time. Many promising approaches explored in laboratories or early studies do not go on to become approved treatments. It is important to remember:

Understanding how research works helps protect people from misinformation, exaggerated claims and unsafe treatment decisions.

If you have questions about vitiligo research, clinical trials, or information you have seen online, The Vitiligo Society can help you sense‑check information and explore next steps safely. While we cannot advise on individual trial participation, we can:

You can contact our team for guidance at: hello@vitiligosociety.org.uk